scholarly journals Development of Lobular Panniculitis Long After Completing the Personalized Peptide Vaccine Therapy

2018 ◽  
Vol 19 ◽  
pp. 1530-1535
Author(s):  
Aira Uchida ◽  
Eiji Kawasaki ◽  
Masayuki Tojikubo ◽  
Hidekazu Tamai ◽  
Yoko Sagara ◽  
...  
Keyword(s):  
Peptide Vaccine ◽  
Vaccine Therapy ◽  
Lobular Panniculitis ◽  
Personalized Peptide Vaccine

Abstract LB-131: Peptide vaccine therapy for childhood gliomas: interim results of a pilot study

2012 ◽  
Author(s):  
Ian F. Pollack ◽  
Regina I. Jakacki ◽  
Lisa H. Butterfield ◽  
Hideho Okada
Keyword(s):  
Pilot Study ◽  
Peptide Vaccine ◽  
Vaccine Therapy

scholarly journals Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

2016 ◽  
Vol 65 (4) ◽  
pp. 849-855 ◽  
Author(s):  
Markus W. Löffler ◽  
P. Anoop Chandran ◽  
Karoline Laske ◽  
Christopher Schroeder ◽  
Irina Bonzheim ◽  
...  
Keyword(s):  
Immune Response ◽  
Peptide Vaccine ◽  
Term Survival ◽  
Long Term Survival ◽  
Personalized Peptide Vaccine

scholarly journals Erratum to “Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient”

2017 ◽  
Vol 66 (1) ◽  
pp. 252-253
Author(s):  
Markus W. Löffler ◽  
P. Anoop Chandran ◽  
Karoline Laske ◽  
Christopher Schroeder ◽  
Irina Bonzheim ◽  
...  
Keyword(s):  
Immune Response ◽  
Peptide Vaccine ◽  
Term Survival ◽  
Long Term Survival ◽  
Personalized Peptide Vaccine

scholarly journals Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy

2013 ◽  
Vol 10 (2) ◽  
pp. 338-343 ◽  
Author(s):  
Shiro Suzuki ◽  
Shiro Suzuki ◽  
Kiyosumi Shibata ◽  
Kiyosumi Shibata ◽  
Fumitaka Kikkawa ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Clinical Response ◽  
Clear Cell ◽  
Clear Cell Carcinoma ◽  
Peptide Vaccine ◽  
Vaccine Therapy ◽  
Ovarian Clear Cell Carcinoma

Phase I trial of personalized peptide vaccine for HLA-A24 positive patients with advanced cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 3079-3079
Author(s):  
M. Terasaki ◽  
M. Noguchi ◽  
S. Naito ◽  
H. Uemura ◽  
H. Akaza ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
Peptide Vaccine ◽  
Personalized Peptide Vaccine

Phase I Clinical Study Assessing Survivin-Derived Peptide Vaccine Therapy for Patients with Advanced or Recurrent Colorectal, Breast or Lung Cancer

2004 ◽  
Vol 27 (6) ◽  
pp. S33
Author(s):  
Toshihiko Torigoe ◽  
Tetsuhiro Tsuruma ◽  
Noriharu Shijyubou ◽  
Kumiko Shimozawa ◽  
Yasuaki Tamura ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Clinical Study ◽  
Phase I ◽  
Peptide Vaccine ◽  
Vaccine Therapy

scholarly journals 884: Phase I Clinical Study of Anti-Apoptosis Protein, Survivin-Derived Peptide Vaccine Therapy for Patients with Advanced or Recurrent Urothelial Cancer

2007 ◽  
Vol 177 (4S) ◽  
pp. 294-294
Author(s):  
Ichiya Homma ◽  
Hiroshi Kitamura ◽  
Toshihiko Torigoe ◽  
Yoshihiko Hirohashi ◽  
Kumiko Shimozawa ◽  
...  
Keyword(s):  
Clinical Study ◽  
Phase I ◽  
Urothelial Cancer ◽  
Peptide Vaccine ◽  
Vaccine Therapy ◽  
Apoptosis Protein
Sign in / Sign up

Export Citation Format

Share Document